Cancer in Special Situations / Population
Here below you will find a list of all the latest content published on this website on the topic of Cancer in Special Situations / Population. The content is published in chronological order.
Areas:
- Cancer in adolescents
- Cancer in young adults
- Cancer in pregnancy
- Cancer in elderly
- AIDS-associated malignancies
- Cancer in patients with comorbidities
- Oligometastatic Disease Classification
- First-line Nivolumab Plus Ipilimumab is Safe and Provides Encouraging Survival in Patients with Advanced NSCLC and Co-Morbidity or Poor Performance Status
- People with Mental Illness Receive Less Cancer Screening
- Unique Factors Impact Outcome in AYA Patients with Cancer
- Social Outcomes after Adolescent and Young Adult Cancer
- First Report of Head and Neck Squamous Cell Carcinoma Treatment Individualised by Geriatric Assessment
- Treatment of Gynaecologic Malignancies During Pregnancy
- FDA Approves Entrectinib for the Treatment of NTRK Fusion-Positive Solid Tumours in Adult and Adolescent Patients
- Communication Between AYA Cancer Patients and Healthcare Professionals Through Digital Media: Handle With Care!
- EMA Recommends Refusal of a Change to the Marketing Authorisation for Eltrombopag
- Greater Awareness Needed of Stomach Cancer Risk in Under-40s, Especially in Latin America [ESMO World GI Press Release]
- FDA Approves Dalteparin Sodium for Venous Thromboembolism in Paediatric Patients
- FDA Approves Ivosidenib as First-Line Treatment for AML with IDH1 Mutation
- Patients aged 75-79 years at higher risk of distant recurrence than patients aged 70-74 years in the older population (>70 years) of patients with early stage breast cancer despite higher competing mortality
- Breast Cancer in Young Women: Good Outcomes with Advised Therapy [ESMO Press Release]
- ESMO Preceptorship on Hereditary Cancer Genetics 2019: Lugano
- Studies give new insights on immunotherapy in elderly patients with advanced NSCLC [ELCC Press Release]
- FDA Expands Approved Use of Palbociclib for Metastatic Breast Cancer
- EMA Recommends Extension of Indications for Plerixafor
- Analysis Compares the Rates of Access of Adolescents and Young Adults to Clinical Trials of New Drugs
- FDA Approves Glasdegib for AML in Adults Age 75 or Older or Who Have Comorbidities
- Drugs for treating breast cancer in women are effective and well tolerated in men [ESMO 2018 Press Release]
- Barriers to early clinical trial access for adolescents and young adults still exist, study shows [ESMO 2018 Press Release]
- Pregnancy may be possible after chemotherapy for breast cancer patients – but many no longer wish to [ESMO 2018 Press Release]
- Risk of Developing Endocrinopathy Determined in Children and Young Adults after Radiotherapy for Brain Tumours